Affordable Access

Safety of Percutaneous Coronary Intervention Without P2Y12 Inhibitor Pretreatment From a Cohort of Unselected Patients.

Authors
  • Lattuca, Benoit
  • Belardi, David
  • Demattei, Christophe
  • Schmutz, Laurent
  • Cornillet, Luc
  • Ledermann, Bertrand
  • Macia, Jean-Christophe
  • Iemmi, Anaïs
  • Gervasoni, Richard
  • Roubille, François
  • Cung, Thien Tri
  • Robert, Pierre
  • MESSNER-PELLENC, PATRICK
  • Leclercq, Florence
  • Cayla, Guillaume
Publication Date
Jul 15, 2018
Source
HAL-INRIA
Keywords
Language
English
License
Unknown
External links

Abstract

Recent studies have challenged systematic pretreatment with a P2Y12 inhibitor before percutaneous coronary intervention (PCI) in elective and non-ST segment elevation myocardial infarction (NSTEMI) patients. The aim of this study was to assess outcomes after performing PCI immediately after coronary angiography with an exclusive "on-the-table" P2Y12 inhibitor loading dose, by evaluating ischemic and bleeding complications in unselected patients.

Report this publication

Statistics

Seen <100 times